These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 21350916

  • 1. Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA.
    Lorson MA, Spate LD, Samuel MS, Murphy CN, Lorson CL, Prather RS, Wells KD.
    Transgenic Res; 2011 Dec; 20(6):1293-304. PubMed ID: 21350916
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
    Feng Z, Ling KK, Zhao X, Zhou C, Karp G, Welch EM, Naryshkin N, Ratni H, Chen KS, Metzger F, Paushkin S, Weetall M, Ko CP.
    Hum Mol Genet; 2016 Mar 01; 25(5):964-75. PubMed ID: 26758873
    [Abstract] [Full Text] [Related]

  • 3. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL.
    Hum Mol Genet; 2013 May 01; 22(9):1843-55. PubMed ID: 23390132
    [Abstract] [Full Text] [Related]

  • 4. Splicing of the Survival Motor Neuron genes and implications for treatment of SMA.
    Bebee TW, Gladman JT, Chandler DS.
    Front Biosci (Landmark Ed); 2010 Jun 01; 15(3):1191-1204. PubMed ID: 20515750
    [Abstract] [Full Text] [Related]

  • 5. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.
    Butchbach MER.
    Int J Mol Sci; 2021 Jul 23; 22(15):. PubMed ID: 34360669
    [Abstract] [Full Text] [Related]

  • 6. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A, Jiang X, He L, Ahmad S, Gangwani L.
    Brain; 2020 Jan 01; 143(1):69-93. PubMed ID: 31828288
    [Abstract] [Full Text] [Related]

  • 7. A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo.
    Dickson A, Osman E, Lorson CL.
    Hum Gene Ther; 2008 Nov 01; 19(11):1307-15. PubMed ID: 19848583
    [Abstract] [Full Text] [Related]

  • 8. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
    Seo J, Singh NN, Ottesen EW, Sivanesan S, Shishimorova M, Singh RN.
    PLoS One; 2016 Nov 01; 11(4):e0154390. PubMed ID: 27111068
    [Abstract] [Full Text] [Related]

  • 9. Advances in therapeutic development for spinal muscular atrophy.
    Howell MD, Singh NN, Singh RN.
    Future Med Chem; 2014 Jun 01; 6(9):1081-99. PubMed ID: 25068989
    [Abstract] [Full Text] [Related]

  • 10. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.
    Workman E, Saieva L, Carrel TL, Crawford TO, Liu D, Lutz C, Beattie CE, Pellizzoni L, Burghes AH.
    Hum Mol Genet; 2009 Jun 15; 18(12):2215-29. PubMed ID: 19329542
    [Abstract] [Full Text] [Related]

  • 11. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M, Ackermann B, Förster A, Jakubik M, Hauke J, Garbes L, Fritzsche I, Mende Y, Blumcke I, Hahnen E, Wirth B.
    Hum Mol Genet; 2010 Apr 15; 19(8):1492-506. PubMed ID: 20097677
    [Abstract] [Full Text] [Related]

  • 12. Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing.
    Dai M, Xu Y, Sun Y, Xiao B, Ying X, Liu Y, Jiang W, Zhang J, Liu X, Ji X.
    Mol Genet Genomics; 2022 Jul 15; 297(4):1039-1048. PubMed ID: 35612622
    [Abstract] [Full Text] [Related]

  • 13. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M, Mattis VB, Lorson CL.
    Drug News Perspect; 2010 Oct 15; 23(8):475-82. PubMed ID: 21031163
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes.
    Singh RN, Singh NN.
    Adv Neurobiol; 2018 Oct 15; 20():31-61. PubMed ID: 29916015
    [Abstract] [Full Text] [Related]

  • 15. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T, Sato H, Lai PS, Nurputra DK, Harahap NI, Morikawa S, Nishimura N, Kurashige T, Ohshita T, Nakajima H, Yamada H, Nishida Y, Toda S, Takanashi J, Takeuchi A, Tohyama Y, Kubo Y, Saito K, Takeshima Y, Matsuo M, Nishio H.
    Brain Dev; 2014 Nov 15; 36(10):914-20. PubMed ID: 24359787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.
    Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ.
    J Neurosci; 2009 Jun 17; 29(24):7633-8. PubMed ID: 19535574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.